Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06637644 · ClinicalTrials.gov registry record
Impella RP Flex with Smart Assist
A clinical trial of Right Ventricular (RV) Dysfunction, sponsored by Abiomed.
- Recruiting
- Registry status
- 200
- Enrollment target
- 20
- Study locations
NCT06637644 is a study of Right Ventricular (RV) Dysfunction that is actively recruiting participants, run by Abiomed. The registered enrollment target is 200 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT06637644, a study of Right Ventricular (RV) Dysfunction, is actively recruiting participants, sponsored by Abiomed.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
To capture observational data of the Abiomed Impella RP Flex in a real-world setting.
Conditions Studied
Interventions
- DEVICE Right-sided ventricular assist device
Study Locations (20)
Arkansas
- Baptist Health Heart Failure and Transplant Institute - Little Rock
- Arkansas Heart Hospital - Little Rock
Florida
- Advent Health Orlando - Orlando
- Tampa General - Tampa
Michigan
- Henry Ford Hospital - Detroit
- Ascension St. John Hospital - Detroit
New York
- Northwell Health/Lenox Hill Hospital - New York
- Montefiore Medical Center - Moses - The Bronx
North Carolina
- Novant Health New Hanover Regional Medical Center - Wilmington
- Wake Forest University School of Medicine - Winston-Salem
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Pima Heart and Vascular - Tucson
California
- University of Southern California (Keck USC) - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-05-29 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06637644
The ClinicalTrials.gov registry entry for NCT06637644 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abiomed, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Right Ventricular (RV) Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Right-sided ventricular assist device is the first listed.
NCT06637644 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Arkansas, Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT06637644 about?
NCT06637644 is a clinical study titled "Impella RP Flex with Smart Assist". To capture observational data of the Abiomed Impella RP Flex in a real-world setting.
What is the current status of trial NCT06637644?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-05-29. Estimated completion is 2026-06-01.
What conditions does trial NCT06637644 study?
This clinical trial studies the following conditions: Right Ventricular (RV) Dysfunction.
What interventions are being tested in trial NCT06637644?
The interventions under investigation include: Right-sided ventricular assist device (DEVICE).
Who is sponsoring clinical trial NCT06637644?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06637644 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.